Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1Phase 2/3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Other 1

Conditions

Multiple Myeloma 31Burkitt Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Mantle-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Biphenotypic, Acute 3Immunoglobulin Light-chain Amyloidosis 3Smoldering Multiple Myeloma 2Recurrence 2Neoplasms, Plasma Cell 2Neoplasms 2Leukemia, Plasma Cell 2Brain Neoplasms 2Blast Crisis 2Renal Insufficiency 1Prostatic Neoplasms 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmacytoma 1Neoplasm Metastasis 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Hodgkin Disease 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × dexamethasone acetate × Clear all
NCT06979596 2026-05-13

OMAHA-015

Merck Sharp & Dohme LLC

Phase 2 Recruiting
250 enrolled
Tumor-Agnostic

Neoplasms

NCT03367156 2025-11-12

Dexamethasone in Controlling Dyspnea in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
135 enrolled 19 charts
Other

Dyspnea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡